Protocol ATX-101-11-23 Titled: Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Sponsor: Kythera Biopharmaceuticals, Inc.

Location(s): United States


This is a Randomized, Double-Blind study evaluating the Safety and Efficacy of ATX-101 in the reduction of submental fat. To evaluate the Safety and Efficacy of ATX-101 subcutaneous injections in the submental area, relative to placebo.